Chinook Therapeutics, Inc. (KDNY) has a market capitalization of $2.71B and trades at $40.39. The 52-week range is 18.34-40.51.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -14.1, Earnings Per Share (EPS) of $-2.87, annual revenue of $6.13M.
The stock has a beta of 0.67, operates in the Healthcare sector.
